Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Antoch

Showing results (21-30 of 443) with videos related to

Pageof 45
Sort By:
Thoracic Surgery Clinics|April 10, 2010
PET versus PET/CT dual-modality imaging in evaluation of lung cancerLutz S Freudenberg, Sandra J Rosenbaum, Thomas Beyer, et al.
PET Clinics|May 10, 2016
PET Versus PET/CT Dual-Modality Imaging in Evaluation of Lung CancerLutz S Freudenberg, Sandra J Rosenbaum, Thomas Beyer, et al.
Radiologic Clinics of North America|August 21, 2007
PET versus PET/CT dual-modality imaging in evaluation of lung cancerLutz S Freudenberg, Sandra J Rosenbaum, Thomas Beyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2004
To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CTGerald Antoch, Lutz S Freudenberg, Thomas Beyer, et al.
Nuclear Medicine Communications|March 6, 2009
Water-equivalent oral contrast agents in dual-modality PET/computed tomography scanning: does a little barium make the difference?Sonja Kinner, Patrick Veit-Haibach, Thomas C Lauenstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 12, 2012
Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphomaChristian Buchbender, Till A Heusner, Thomas C Lauenstein, et al.
Anticancer Research|March 9, 2012
Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA - a pilot studyChristian Arsov, Michael Quentin, Robert Rabenalt, et al.
World Journal of Gastroenterology|May 12, 2006
Accuracy of combined PET/CT in image-guided interventions of liver lesions: an ex-vivo studyPatrick Veit, Christiane Kuehle, Thomas Beyer, et al.
European Radiology|May 4, 2005
Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial resultsPatrick Veit, Gerald Antoch, Hrvoje Stergar, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 5, 2017
Non-gaussian diffusion evaluation of the human kidney by Padé exponent modelAlexandra Ljimani, Rotem S Lanzman, Anja Müller-Lutz, et al.
Pageof 45

Showing results (21-30 of 443) with videos related to

Sort By:
Pageof 45
Thoracic Surgery Clinics|April 10, 2010
PET versus PET/CT dual-modality imaging in evaluation of lung cancerLutz S Freudenberg, Sandra J Rosenbaum, Thomas Beyer, et al.
PET Clinics|May 10, 2016
PET Versus PET/CT Dual-Modality Imaging in Evaluation of Lung CancerLutz S Freudenberg, Sandra J Rosenbaum, Thomas Beyer, et al.
Radiologic Clinics of North America|August 21, 2007
PET versus PET/CT dual-modality imaging in evaluation of lung cancerLutz S Freudenberg, Sandra J Rosenbaum, Thomas Beyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2004
To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CTGerald Antoch, Lutz S Freudenberg, Thomas Beyer, et al.
Nuclear Medicine Communications|March 6, 2009
Water-equivalent oral contrast agents in dual-modality PET/computed tomography scanning: does a little barium make the difference?Sonja Kinner, Patrick Veit-Haibach, Thomas C Lauenstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 12, 2012
Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphomaChristian Buchbender, Till A Heusner, Thomas C Lauenstein, et al.
Anticancer Research|March 9, 2012
Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA - a pilot studyChristian Arsov, Michael Quentin, Robert Rabenalt, et al.
World Journal of Gastroenterology|May 12, 2006
Accuracy of combined PET/CT in image-guided interventions of liver lesions: an ex-vivo studyPatrick Veit, Christiane Kuehle, Thomas Beyer, et al.
European Radiology|May 4, 2005
Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial resultsPatrick Veit, Gerald Antoch, Hrvoje Stergar, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 5, 2017
Non-gaussian diffusion evaluation of the human kidney by Padé exponent modelAlexandra Ljimani, Rotem S Lanzman, Anja Müller-Lutz, et al.
Pageof 45